| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7872049 | POHL BOSKAMP | Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate |
Mar, 2029
(4 years from now) | |
Nitrolingual Pumpspray is owned by Pohl Boskamp.
Nitrolingual Pumpspray contains Nitroglycerin.
Nitrolingual Pumpspray has a total of 1 drug patent out of which 0 drug patents have expired.
Nitrolingual Pumpspray was authorised for market use on 31 October, 1985.
Nitrolingual Pumpspray is available in spray, metered;sublingual dosage forms.
Nitrolingual Pumpspray can be used as method of treating angina pectoris.
The generics of Nitrolingual Pumpspray are possible to be released after 12 March, 2029.
Drugs and Companies using NITROGLYCERIN ingredient
Market Authorisation Date: 31 October, 1985
Treatment: Method of treating angina pectoris
Dosage: SPRAY, METERED;SUBLINGUAL
How can I launch a generic of NITROLINGUAL PUMPSPRAY before it's drug patent expiration?
More Information on Dosage
NITROLINGUAL PUMPSPRAY family patents
